Jiarou Wang

Safety and efficacy of peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors

Yuanyuan Jiang, Qingxing Liu, Guochang Wang et al. · Theranostics · 2022 · 23 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer

Guochang Wang, Linlin Li, Ming Zhu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 17 citations · Full text

Medicine, Nuclear Medicine, Oncology +14

Synthesis, preclinical evaluation and pilot clinical translation of [68Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancer

Rongxi Wang, Zhidong Bai, Wentao Zhong et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 16 citations

Medicine, Oncology, Pharmacology +17

A prospective head-to-head comparison of 68 Ga-NOTA-3P-TATE-RGD and 68 Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours

Yuanyuan Jiang, Qingxing Liu, Guochang Wang et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 11 citations

Medicine, Nuclear Medicine, Oncology +14

Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study

Linlin Li, Jiarou Wang, Guochang Wang et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 11 citations

Medicine, Oncology, Pharmacology +14